Streetbeat News

Equity Actions

VTR

Analysts have diverse opinions on Ventas (NYSE:VTR), with recent evaluations showing a shift towards a more bullish stance. The average 12-month price target for VTR has increased to $53.0, reflecting a 4.95% rise from the previous target. Analysts from firms like Evercore ISI Group, Wells Fargo, Deutsche Bank, B of A Securities, and Mizuho have updated their ratings and price targets, indicating a positive outlook on the company's performance. Ventas, with a diversified healthcare portfolio, has shown a revenue growth of 10.74% as of December 31, 2023, but faces challenges in net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 2:00 pm

DRVN

Driven Brands Hldgs (NASDAQ:DRVN) has received mixed analyst ratings over the past quarter, with a shift towards a more bullish stance in the last 30 days. The average 12-month price target is $18.00, marking a 13.59% decline from the previous target. Analysts from firms including Canaccord Genuity, RBC Capital, Piper Sandler, JP Morgan, and Morgan Stanley have adjusted their ratings and price targets, reflecting various market conditions and company performance. Driven Brands, a North American automotive services company, shows a positive revenue trend but faces challenges in market capitalization, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 2:00 pm

SMCI

Supermicro's stock price is on the rise following its inclusion in the S&P 500 Index, reflecting a positive market response.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 1:18 pm

COHR

Coherent's (NYSE:COHR) short interest has increased by 9.95% since the last report, with 5.02 million shares sold short, representing 4.42% of its float. This indicates a bearish market sentiment towards COHR, although it's higher than its peer group average of 3.34% short interest. The article suggests that an increase in short interest can sometimes be bullish, as it may lead to a short squeeze.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 1:15 pm

RARE

Ultragenyx Pharmaceutical (NASDAQ:RARE) received mixed analyst ratings with an average 12-month price target of $92.75, marking a 20.14% increase from the previous target. The company's financial health shows strong revenue growth and efficient cost management but faces challenges in ROE and ROA. Its market capitalization is below industry benchmarks, indicating potential growth constraints.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 1:00 pm

QD

Qudian Inc. announced a share repurchase program of up to $300 million and reported its Q4 financial results, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 12:41 pm

NXT

Nextracker (NASDAQ:NXT) announces Charles 'Chuck' Boynton as the new CFO, effective May 2024, succeeding David Bennett who will become CAO. Boynton, with over 30 years in finance and significant solar industry experience, aims to enhance Nextracker's growth and shareholder returns. Bennett, transitioning from CFO to CAO, has been instrumental in Nextracker's IPO and its spin-out from Flex.

Portfolio Pulse from Happy Mohamed

March 18, 2024 | 12:40 pm

MBLY

Mobileye announced it will wind down its aftermarket solutions unit, stating this move will not materially impact its 2024 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 12:40 pm

NRXP

NRx Pharmaceuticals plans to distribute 49% of HOPE Therapeutics stock and a 1% royalty right on Ketamine sales to its shareholders. The Board of Directors has authorized necessary steps to effectuate this dividend and royalty rights distribution, pending completion of legal, accounting, and regulatory requirements.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 12:35 pm

CEG

Constellation (NASDAQ:CEG) has issued the first corporate green bond in the U.S. for $900 million with a 30-year term to finance nuclear energy projects. This initiative underscores the role of nuclear energy in achieving sustainability goals and marks a significant step in green financing. The bond will fund investments in maintenance, expansion, and life extensions of nuclear power generation. Crédit Agricole CIB served as the Green Structuring agent for this offering, which aligns with the Green Bond Principles and Green Loan Principles.

Portfolio Pulse from Happy Mohamed

March 18, 2024 | 12:22 pm